Does NIVOLUMAB Cause Hyperthyroidism? 934 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 934 reports of Hyperthyroidism have been filed in association with NIVOLUMAB (OPDIVO). This represents 1.1% of all adverse event reports for NIVOLUMAB.
934
Reports of Hyperthyroidism with NIVOLUMAB
1.1%
of all NIVOLUMAB reports
93
Deaths
511
Hospitalizations
How Dangerous Is Hyperthyroidism From NIVOLUMAB?
Of the 934 reports, 93 (10.0%) resulted in death, 511 (54.7%) required hospitalization, and 82 (8.8%) were considered life-threatening.
Is Hyperthyroidism Listed in the Official Label?
Yes, Hyperthyroidism is listed as a known adverse reaction in the official FDA drug label for NIVOLUMAB.
What Other Side Effects Does NIVOLUMAB Cause?
Death (11,216)
Malignant neoplasm progression (9,363)
Off label use (5,208)
Diarrhoea (4,692)
Fatigue (3,709)
Pyrexia (3,454)
Intentional product use issue (3,297)
Rash (2,816)
Nausea (2,805)
Decreased appetite (2,619)
What Other Drugs Cause Hyperthyroidism?
LEVOTHYROXINE (1,681)
AMIODARONE (1,410)
PEMBROLIZUMAB (780)
IPILIMUMAB (525)
CARBOPLATIN (432)
ATEZOLIZUMAB (416)
PACLITAXEL (261)
ALEMTUZUMAB (236)
LENVATINIB (231)
PREDNISONE (220)
Which NIVOLUMAB Alternatives Have Lower Hyperthyroidism Risk?
NIVOLUMAB vs NIVOLUMAB\RELATLIMAB-RMBW
NIVOLUMAB vs NIZATIDINE
NIVOLUMAB vs NOMEGESTROL
NIVOLUMAB vs NORDAZEPAM
NIVOLUMAB vs NOREPINEPHRINE